Eli Lilly

Eli Lilly Says Most Employees Won't See Raises in Base Salary This Year
WSJ Online
Mon, 03/24/14 - 06:32 pm
Eli Lilly
salaries
Boehringer, Lilly Diabetes Drug Wins EU Panel’s Backing
Bloomberg
Fri, 03/21/14 - 09:41 am
Jardiance
diabetes
Boehringer Ingelheim
Eli Lilly
Europe
Novo Nordisk sees chance of U.S. Tresiba launch before rival products
Yahoo/Reuters
Thu, 03/20/14 - 05:35 pm
Novo Nordisk
insulin
diabetes
Tresiba
Lantus
Sanofi
Eli Lilly
Can Biogen Catch up to Merck in Alzheimer's Race?
Motley Fool
Wed, 03/12/14 - 02:58 pm
Biogen Idec
Merck
Alzheimer's disease
E2609
bapineuzumab
LY2886721
Eli Lilly
Tecfidera
Four Upcoming Catalysts That Could Move Pharmaceutical Stocks
Yahoo/24-7 Wall St
Mon, 03/10/14 - 10:13 am
Eli Lilly
Bristol-Myers Squibb
Merck
Pfizer
Yervoy
palbociclib
animal health
ramucirumab
What Does This Rejection Mean for Eli Lilly?
Motley Fool
Fri, 03/7/14 - 09:24 am
Eli Lilly
FDA
empagliflozin
Boehringer Ingelheim
Can Merck Outperform AbbVie and Eli Lilly in 2014?
Motley Fool
Thu, 03/6/14 - 11:36 am
AbbVie
Eli Lilly
Merck
Can Diabetes Treatments Replace Patent Losses At Eli Lilly & Co?
Motley Fool
Thu, 03/6/14 - 10:17 am
Eli Lilly
diabetes
patents
dulaglutide
GLP-1 agonist
Novo Nordisk
AstraZeneca
GSK
JNJ
Lilly’s Diabetes Pill Rejected by FDA Over Manufacturing
Bloomberg
Wed, 03/5/14 - 11:44 am
FDA
Eli Lilly
diabetes
empagliflozin
Boehringer Ingelheim
Lilly, Pfizer and Merck slash doctor payments, but J&J and Forest shell out more
Fierce Pharma
Tue, 03/4/14 - 10:30 pm
physician payments
Pfizer
Merck
JNJ
Forest Labs
Eli Lilly
Teva announces approval of generic to Lilly's Evista
The Fly on the Wall
Tue, 03/4/14 - 12:26 pm
Teva Pharmaceuticals
Eli Lilly
Evista
generics
3 Top Pharmaceuticals: Patents, Pipelines And Prospects
Seeking Alpha
Mon, 03/3/14 - 10:06 am
patents
JNJ
Eli Lilly
Pfizer
Eli Lilly Gains Slightly on Dulaglutide Data
Yahoo/Zacks.com
Thu, 02/27/14 - 04:56 pm
Eli Lilly
dulaglutide
diabetes
Who loses most in Lilly vs. Novo diabetes study? AstraZeneca
Fierce Pharma
Wed, 02/26/14 - 07:03 pm
Victoza
Novo Nordisk
Eli Lilly
dulaglutide
diabetes
Bydureon
AstraZeneca
Clock Is Ticking For AstraZeneca
Forbes
Tue, 02/25/14 - 03:57 pm
AstraZeneca
dulaglutide
GSK
Eli Lilly
Bydureon
diabetes
Lilly weekly diabetes drug succeeds vs market leader Victoza -study
Yahoo/Reuters
Tue, 02/25/14 - 08:15 am
Eli Lilly
diabetes
Victoza
Novo Nordisk
dulaglutide
Public Citizen says FDA should add heart warning to popular testosterone drugs for men
Yahoo/AP
Tue, 02/25/14 - 07:27 am
FDA
testosterone
Public Citizen
Androgel
Androderm
Fortesta
Axiron
Watson Pharmaceuticals
AbbVie
Eli Lilly
Endo Health Solutions
5 Pharmas Spending the Most to Develop Drugs: Merck, AstraZeneca, Roche, Bristol, and Lilly
Motley Fool
Tue, 02/25/14 - 07:22 am
Merck
AstraZeneca
Roche
Bristol-Myers Squibb
Eli Lilly
R&D
drug development
Attack On Lung Cancer: Eli Lilly Vs. Rivals
Seeking Alpha
Mon, 02/24/14 - 09:53 am
Eli Lilly
non-small cell lung cancer
Roche
ramucirumab
Sanofi
Lilly Agrees to Buy Animal Health Firm, Cuts Outlook
Marketwatch
Mon, 02/24/14 - 09:00 am
M&A
animal health
Eli Lilly
Elanco
Lohmann SE

Pages